Skin of Color
Ronald Prussick, MD
From new toxins to new thoughts on duration of effect to micro injections, the toxin market is growing in dermatology.
Michael Gold, MD, FAAD
A look at injectable aesthetics on the horizon.
Hassan Galadari, MD
From a recent approval to a late-stage candidate, the field is evolving. Experts weigh in on the latest.
With Ava Shamban, MD and Jeffrey Dover, MD
A popular aesthetic treatment may have an added benefit when used in the periocular area.
Sandra Marchese Johnson, MD
Dermatologic surgeons spend their days bent over exam tables to perform procedures. Their backs may suffer.
Gaurav Singh, MD, MPH
The transition is natural for many practices. Key is to set and follow a plan.
Kim Campbell; and Suneel Chilukuri, MD
With Noelani González, MD
Complaints and concerns abound, but remedies are slow in coming.
With Michelle Henry, MD
An ethical and fair “How-To” for terminating physician-patient relationships.
Kim Nichols, MD, FAAD, Emily Scalise, MA, and Shaina Gregory
The benefits of timed sequential therapy.
Gary Goldenberg, MD
How Mirvaso fits into the current treatment armamentarium for rosacea.
Joel L. Cohen, MD
An update on skin moisturization and the use of prescription barrier repair agents for atopic dermatitis.
Andrew C. Krakowski, MD, FAAD
New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown.
Lisa Prussick, BS and Ronald Prussick, MD
Effective patient outreach improves outcomes, saves lives, and increases practice revenue.
Steven Leon, MS, PA-C
Pulse therapy under physician supervision can reduce long-term exposure and help reduce the risk of untoward effects of hydroquinone therapy.
Zein E. Obagi, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.